Extrait

Investigators propose to assess,the safety and tolerability profile (number of participants with adverse events)of bevacizumab (Avastin) when combined with standard chemotherapy as first line treatment of patients with metastatic Breast Cancer.

Critère d'inclusion

• Metastatic breast cancer

Liens

• nct
• ictrp